查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2022-2029 年語音重建設備的全球市場
市場調查報告書
商品編碼
1153811

2022-2029 年語音重建設備的全球市場

Global Voice Restoration Devices Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概覽

語音重建設備的全球市場預計將在 2021 年達到 5.3129 億美元，在 2029 年達到 6.0275 億美元，在預測期內（2022-2029 年）以 9.58% 的複合年增長率增長。

語音重建設備與食管語音和拇指造口阻塞等語音療法結合使用，以幫助喉切除術患者恢復語音。在許多情況下，喉癌會導致聲帶被切除。在這種情況下，您將需要使用設備或植入物進行特定的聲音恢復治療。

市場動態

對這些語音恢復設備的需求增加、喉癌發病率上升、研發支出增加以及新產品推出的增加預計將推動市場增長。

新產品的推出和對語音重建設備不斷增長的需求將推動市場增長。

語音重建設備的全球市場主要受到醫療保健行業語音重建設備需求激增、產品發布數量增加以及這些電子喉的諸多好處的推動。已經對有利於語音恢復的新型微創耳鼻喉手術進行了各種研究。例如，2021年10月，開發Blom-Singer語音恢復等耳鼻喉產品的InHealth Technology宣布推出Blom-Singer Speak free HME免提閥。該產品將使接受全喉切除術的患者受益。

隨著各種最新的創新，語音重建設備的數量不斷增加，需求也越來越大。這些設備的最新創新正在推動市場的增長。例如，Orvisana Healthcare 的 Servox Digital XL Electrolarynx 是一種人工聲帶設備，可通過複製聲帶的活動來放大語音。對接受過氣管切開手術的人有效。可以通過設置更改音量和頻率。

與語音重建設備相關的高成本阻礙了市場的增長。

然而，設備和程序的高成本會抑制市場潛力。市場上有各種類型的音頻助聽器和方法。由於預算不足，許多中小型診所無法訂購和預付各種品牌和尺寸的最小庫存設備。氣動喉裝置的價格從大約 75 美元到 150 美元不等，頸式電子喉裝置的價格從 150 美元到 800 美元不等。

COVID-19 影響分析

疫情對全球金融預期、運營和危機應對策略產生了負面影響。市場進入者正在改變他們的長期和短期增長戰略，利用研究市場創造尖端項目來對抗這一流行病。即使 COVID-19 損害了行業，重要的是要為您的業務運營製定並儘快制定備份計劃。世界各地正在進行各種合作和合併，推動了市場的增長。例如，2022 年 1 月，ICU Medical 收購了醫療器械製造商 Smith's Medical。

內容

第 1 章市場研究方法和範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

第四章市場動態

  • 市場影響因素
    • 司機
      • 新產品發布次數增加
      • 對語音重建設備的需求增加
    • 約束因素
      • 與這些設備相關的高成本
    • 商機
    • 影響分析

第五章行業分析

  • 搬運工的五種力量
  • 未滿足的需求
  • 供應鏈分析
  • 監管分析

第 6 章 COVID-19 分析

  • COVID-19 市場分析
    • COVID-19 之前的市場情景
    • COVID-19 的當前市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 總結

第 7 章按設備類型

  • 人工喉（電子喉）
  • 用於氣管食管的人工聲帶
    • Probox 人工聲帶
    • Blomsinger 假肢
    • Nydam 人工聲帶
    • 格羅寧根語音假體

第 8 章按產品壽命分類

  • 12 個月或更長時間
  • 6 到 12 個月
  • 少於 6 個月

第 9 章最終用戶

  • 多學科醫院
  • 耳鼻喉科醫院
  • 門診手術中心

第10章按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第11章競爭格局

  • 主要發展和戰略
  • 公司股票分析
  • 產品基準
  • 值得關注的主要公司名單

第12章公司簡介

  • Atos Medical（Coloplast）
    • 公司概況
    • 產品組合和說明
    • 主要亮點
    • 財務摘要
  • Inhealth Technologies
  • Freudenberg Medical
  • Luminaud Inc.
  • Romet Electronic Larynx
  • Smith's Medical（ICU Medical）
  • Sanova Holding AG
  • Orbisana Healthcare
  • Acclarent Inc.（Johnson & Johnson）
  • William Demant Holdings

第13章 聲音重建設備的全球市場-DataM

簡介目錄
Product Code: DMMD689

Market Overview

The global voice restoration devices market was valued at US$ 531.29 million in 2021 and is estimated to reach US$ 602.75 million by 2029, growing at a CAGR of 9.58% during the forecast period (2022-2029).

Voice restoration devices are used with voice therapy, such as esophageal speech and stoma occlusion with the thumb, to help laryngectomy patients produce a statement. In most cases, the voice box is removed due to larynx cancer. The patient has to undergo specific voice restoration therapy involving devices and implants.

Market Dynamics

The increasing demand for these voice restoration devices, the rising incidence of larynx cancer, the increasing research and development expenditure and growth in novel product launches are expected to drive market growth.

The increasing novel product launches and demand for voice restoration devices will drive market growth.

The global market for voice restoration devices is primarily driven by the surge in demand for voice restoration devices in the healthcare industry, the rising number of product launches, and the many advantages of these electrolarynxes. Various studies are being conducted on novel minimally invasive ENT procedures that benefit voice restoration. For instance, in Oct 2021, InHealth Technology, a company that develops ENT products such as Blom-Singer voice restoration, announced the launch of the Blom-Singer Speak free HME hands-free valve. This product will be advantageous for patients who have undergone total laryngectomy.

Various latest technological advancements are taking place, and the number of voice restoration device launches is increasing, increasing the demand. The latest innovations in these devices are driving the growth of the market. For instance, Orbisana Healthcare's product Servox Digital XL electrolarynx is a voice prosthesis device that copies the activity of the voice box and amplifies the speech. It can be useful for individuals got tracheotomy procedures. Volume and frequency can be changed from settings.

High costs associated with voice restoration devices will hamper the market's growth.

However, the high cost of devices and procedures might hamper the market potential. Various types of voice prostheses and methods are available in the market. Many small and medium-sized clinics cannot order and prepay for a minimum stock of different brands and sizes of devices due to a lack of budget. The price of pneumatic artificial larynx devices ranges from approximately USD 75 to USD 150, while the neck-type electrolarynx device's price varies from USD 150 to USD 800.

COVID-19 Impact Analysis

The pandemic has negatively impacted global financial expectations, operations and crisis response strategy. Market participants are changing their long-term and short-term growth strategies by utilizing the research market and creating cutting-edge items to combat the pandemic. Even though COVID-19 harms the industry, preparing and implementing backup plans as soon as possible for business operations is crucial. Various collaborations and mergers are happening worldwide, boosting the market's growth. For instance, in Jan 2022, ICU Medical acquired Smith's Medical, a medical device manufacturer.

Segment Analysis

The artificial larynx (Electrolarynx) segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The artificial larynx (Electrolarynx) segment is the highest market holder in the global voice restoration devices market. The artificial larynx (Electrolarynx) is the leading device type in the market, holding a dominant share. Electrolarynx is a vibrator that is externally operated and is placed on the chin or cheeks; that generates vibrations in the throat that are further converted into speech from the mouth of the patient. A significant advantage of the artificial larynx is that its use is often quickly and rapidly learned and is now available latest hand-free devices. The devices, specifical valves, are made of silicone in voice prosthesis and electronically operated devices in an electrolarynx. According to the NIH, in 2021, larynx cancer caused approximately 0.6% of deaths and 0.7% of new cases of all cancers globally. The novel development of innovative and advanced electrolarynx is increasing market growth. For instance, Romet Electronic Larynx introduced its Romet R700 Clarity programmable digital electronic larynx. It is a digital electrolarynx device that laryngectomy patients use. This digital device produces some mechanical vibrations having a low sound frequency of around 60-195 Hz. In the neck, these vibrations develop trembling in the oral cavity, which is the same as the human voice. Combining the starting and stopping sound vibrations with oral articulation generates human speech.

Geographical Analysis

North America holds the largest market share of the global voice restoration devices market.

North America dominates the global voice restoration devices market, primarily attributed to the increasing number of partnerships or collaborations between companies, the rising demand for voice restoration devices, and novel studies. Furthermore, factors including growing expenditure on research and development, the increasing incidence of laryngeal and hypopharyngeal cancer, and the adoption of voice restoration devices among patients will likely enhance the growth of the region's voice restoration devices market. The American Cancer Society estimated that about 12,470 new laryngeal cancer cases would be registered in the U.S. in 2022, out of which 3,820 people are expected to die from laryngeal cancer.

Moreover, the growing number of product launches is responsible for the market's growth. Other factors, such as the high spending of GDP on healthcare, stimulate the market's growth. Many key developments and technological advancements are taking place based in this region. For instance, in Sep 2021, Acclarent Inc, a subsidiary of Johnson & Johnson company of medical devices, developed minimally invasive ENT technologies and launched its AI-powered ENT technology. This technology simplifies surgical planning, and it provides real-time feedback during ENT navigation procedures.

Competitive Landscape

The voice restoration devices market is highly competitive with local and global companies. Atos Medical, Inhealth Technologies, Freudenberg Medical, Luminaud Inc., Romet Electronic Larynx, Smith's Medical (ICU Medical), Sanova Holding AG, Orbisana Healthcare, Acclarent Inc. (Johnson & Johnson), William Demant Holdings and more. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the market's growth. For instance, in Oct 2022, Coloplast completed the acquisition of Atos Medical, an innovative medical device developer in laryngectomy and tracheostomy, after receiving the regulatory authority's approval. This will lead to the addition of new ENT and Respiratory care in Coloplast's business segment.

Atos Medical (Coloplast):

Overview:

Atos Medical is a company that designs and commercializes innovative medical devices in laryngectomy and tracheostomy. It was founded in 1986 and is headquartered in Malmo, Sweden. Atos provides its products in around 90 countries.

Product Portfolio:

Provox ActiValve: It is a prosthesis device specially developed for patients facing early leakage problems from voice prostheses. The valve flap and ring are fluoroplastic material that prevents candida destruction. While breathing and swallowing, the inadvertent opening of the valve flap will be prevented by the magnets.

The global voice restoration devices market report would provide access to approximately 40+ market data tables, 45+ figures, and 200 (approximate) pages.

Table of Contents

1. Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The rising novel product launches
      • 4.1.1.2. Increasing demand for voice restoration devices
    • 4.1.2. Restraints:
      • 4.1.2.1. High cost associated with these devices
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces
  • 5.2. Unmet Needs
  • 5.3. Supply chain Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Device Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 7.1.2. Market Attractiveness Index, By Device Type
  • 7.2. Artificial Larynx (Electrolarynx) *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Tracheoesophageal Voice Prosthesis
    • 7.3.1. Provox Voice Prosthesis
    • 7.3.2. Blom-Singer Prosthesis
    • 7.3.3. Nijdam Voice Prosthesis
    • 7.3.4. Groningen Voice Prosthesis

8. By Device Lifespan

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Lifespan
    • 8.1.2. Market Attractiveness Index, By Device Lifespan
  • 8.2. More than 12 Months *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. 6-12 Months
  • 8.4. Less than 6 Months

9. By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Multi-Specialty Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. ENT Hospitals
  • 9.4. Ambulatory Surgical Centres

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Lifespan
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), End-User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. The U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Lifespan
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), End-User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. The U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Lifespan
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), End-User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Lifespan
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), End-User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Lifespan
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), End-User
    • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country

11. Competitive Landscape

  • 11.1. Key Developments and Strategies
  • 11.2. Company Share Analysis
  • 11.3. Product Benchmarking
  • 11.4. List of Key Companies to Watch

12. Company Profiles

  • 12.1. Atos Medical (Coloplast)
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Inhealth Technologies
  • 12.3. Freudenberg Medical
  • 12.4. Luminaud Inc.
  • 12.5. Romet Electronic Larynx
  • 12.6. Smith's Medical (ICU Medical)
  • 12.7. Sanova Holding AG
  • 12.8. Orbisana Healthcare
  • 12.9. Acclarent Inc. (Johnson & Johnson)
  • 12.10. William Demant Holdings

LIST NOT EXHAUSTIVE

13. Global Voice Restoration Devices Market- DataM

  • 13.1. Appendix
  • 13.2. About Us and Services
  • 13.3. Contact Us